you are viewing a single comment's thread.
One more question....They said "Four of the 8 patients continue to receive TH-302 after receiving TH-302 for 2.6 to 6.2 months"Why did 4 of the 8 trial patients stop treatment? Does not sound good at all. I'm watching this one for a pump and dump. Insiders bought stock and then publish this ridiculous nonsense that really gives you no real information? Very interesting.